Evidence map›Paper›PMID 42181811›Full record

ArticleEuropean heart journal. Case reports2026

Non-contrast

Krishnarpan Chatterjee, Mohamed Ali, Mohammad Alkhalil

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krishnarpan ChatterjeeCardiothoracic Centre, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, UK.
Mohamed AliCardiothoracic Centre, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, UK.
Mohammad AlkhalilCardiothoracic Centre, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, UK.ORCID https://orcid.org/0000-0002-3088-8878

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Concomitant aortic stenosis and chronic kidney disease (CKD) represent management challenges. Transcatheter aortic valve implantation (TAVI) is an established treatment for patients with symptomatic severe aortic stenosis but requires the use of contrast media, particularly in patients undergoing self-expanding platform implantation. Therefore, patients with CKD remain at an increased risk of developing worsening renal impairment post TAVI. Case summary: Herein, we present a 62-year-old male patient who was admitted with progressive dyspnoea. His transthoracic echocardiogram revealed severe aortic stenosis and impaired left ventricular systolic function (an estimated ejection fraction of 35%). He has a background of porcelain aorta and CKD. Despite low-dose contrast CT, the patient's renal function significantly deteriorated. He was successfully treated with Conclusion: This case demonstrated the feasibility of implanting a self-expanding

Indexed as

Aortic stenosisCase reportEvolutRenal impairmentSelf-expandingTranscatheter aortic valve implantation

Identifiers

PMID42181811
PMCPMC13197055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.